These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2407266)

  • 1. Some problems with antihypertensive drug studies in the context of the new guidelines.
    Rose M; McMahon FG
    Am J Hypertens; 1990 Feb; 3(2):151-5. PubMed ID: 2407266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trough/peak ratios for antihypertensive agents. The issues in perspective.
    Meredith PA
    Drugs; 1994 Nov; 48(5):662-6. PubMed ID: 7530624
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
    Lipicky R
    J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
    Meredith PA
    J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016.
    Khan A; Fahl Mar K; Schilling J; Brown WA
    PLoS One; 2018; 13(2):e0193043. PubMed ID: 29489874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative doses of four antihypertensive drugs.
    Griffith DN; James IM; Symons C
    Br J Clin Pharmacol; 1979 Jun; 7(6):633-4. PubMed ID: 465289
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of ambulatory blood pressure measurement to the evaluation of new antihypertensive drugs.
    Reid JL; Bainbridge AD; MacFadyen RJ
    J Hypertens Suppl; 1991 Dec; 9(8):S54-6. PubMed ID: 1795202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test of a novel method for analysis of the efficacy of antihypertensive drugs.
    Wilson AL; Schumacher GE
    Lancet; 1979 Mar; 1(8117):656-8. PubMed ID: 85882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatment and trough: peak ratio: general considerations.
    Meredith PA; Elliott HL
    J Hypertens Suppl; 1994 Nov; 12(8):S79-82; discussion S83. PubMed ID: 7707161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepant antihypertensive dose recommendations.
    Milic M; Ziegler MG
    Clin Exp Hypertens; 2006 Feb; 28(2):171-80. PubMed ID: 16546842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How many antihypertensives do patients need to achieve a target blood pressure?
    Marshall T
    J Hum Hypertens; 2005 Apr; 19(4):317-9. PubMed ID: 15660116
    [No Abstract]   [Full Text] [Related]  

  • 15. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations.
    Lipicky RJ
    J Hypertens Suppl; 1994 Nov; 12(8):S17-8; discussion S18-9. PubMed ID: 7707150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure in relation to drug treatment and clinical trials.
    Conway J; Coats A; Radaelli A
    J Hypertens Suppl; 1990 Dec; 8(6):S83-5. PubMed ID: 2082003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure lowering efficacy of loop diuretics for primary hypertension.
    Musini VM; Rezapour P; Wright JM; Bassett K; Jauca CD
    Cochrane Database Syst Rev; 2012 Aug; (8):CD003825. PubMed ID: 22895937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDR provides latest Food and Drug Administration-approved dosage guidelines.
    Mehta M
    Arch Intern Med; 2001 Nov; 161(21):2622; author reply 2623. PubMed ID: 11718598
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.